# US 2012/0258925 A1 · Antibacterial aminoglycoside analogs

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0258925 A1
- Document ID: US20120258925A1
- Status: Published application
- Kind: A1
- Application number: 13/441,696
- Filed: 2012-04-06
- Published: 2012-10-11
- Earliest claimed: 2009-10-09
- Assignees: Achaogen, Inc.
- Inventors: James Bradley Aggen; Paola Dozzo; Adam Aaron Goldblum; Darin James Hildebrandt; Timothy Robert Kane; Micah James Gliedt; Martin Sheringham Linsell
- Web page: https://patentgrep.com/patent/US20120258925A1

## CPC

- C07H 15/232: with at least three saccharide radicals in the molecule, e.g. lividomycin, neomycin, paromomycin
- A61P 31/04: Antibacterial agents
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Compounds having antibacterial activity are disclosed. The compounds have the following structure (I): including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q1, Q2, Q5, R1, R2, R3, Z1 and Z2 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.

## Claims

### Claim 1

A compound having the following structure (I):
or a stereoisomer, prodrug or pharmaceutically acceptable salt thereof,
wherein:
Q1 is hydroxyl, a protected hydroxyl, amino or a protected amino group;
Q2 is:
Q5 is hydroxyl, a protected hydroxyl, amino or a protected amino group;
each R1 and R2 is, independently, hydrogen or an amino protecting group;
each R3 is, independently, hydrogen or a hydroxyl protecting group;
each R4 and R5 is, independently, hydrogen or C1-C6 alkyl optionally substituted with one or more halogen, hydroxyl or amino;
each R6 is, independently, hydrogen, halogen, hydroxyl, amino or C1-C6 alkyl;
or R4 and R5 together with the atoms to which they are attached can form a heterocyclic ring having from 4 to 6 ring atoms, or R5 and one R6 together with the atoms to which they are attached can form a heterocyclic ring having from 3 to 6 ring atoms, or R4 and one R6 together with the atoms to which they are attached can form a carbocyclic ring having from 3 to 6 ring atoms;
each n is, independently, an integer from 0 to 4; and
each Z1 and Z2 is, independently, hydrogen or —OR3,
wherein (i) at least one of Z1 and Z2 is H, (ii) at least one of R4 and R5 is substituted C1-C6 alkyl or at least one R6 is halogen, hydroxyl or amino, and (iii) the two adjacent —CH— groups to which Z1 and Z2 are attached may optionally form a double bond.

### Claim 2 (depends on 1)

A compound of claim 1 wherein each R1, R2 and R3 are hydrogen.

### Claim 3

(canceled)

### Claim 4 (depends on 1)

A compound of claim 1 wherein Q5 is hydroxyl.

### Claim 5 (depends on 1)

A compound of claim 1 wherein Q1 is amino.

### Claim at position 6

6-7. (canceled)

### Claim 8 (depends on 1)

A compound of claim 1 wherein Z1 is hydroxyl and Z2 is hydrogen.

### Claim 9 (depends on 1)

A compound of claim 1 wherein Z1 is hydrogen and Z2 is hydroxyl.

### Claim 10 (depends on 1)

A compound of claim 1 wherein Q2 is:
wherein:
R4 is hydrogen;
R5 is hydrogen;
at least one R6 is halogen; and
n is an integer from 1 to 4.

### Claim 11 (depends on 10)

A compound of claim 10 wherein Q2 is:
wherein each R6 is halogen.

### Claim 12

(canceled)

### Claim 13 (depends on 1)

A compound of claim 1 wherein Q2 is:
wherein:
R4 is hydrogen;
R5 is hydrogen;
at least one R6 is hydroxyl; and
n is an integer from 1 to 4.

### Claim 14 (depends on 13)

A compound of claim 13 wherein Q2 is:

### Claim at position 14

15-18. (canceled)

### Claim 19 (depends on 1)

A compound of claim 1 having the configuration:

### Claim 20

(canceled)

### Claim 21 (depends on 1)

A compound of claim 1 wherein the two adjacent carbon atoms to which Z1 and Z2 are attached form a single bond.

### Claim 22 (depends on 1)

A compound of claim 1, wherein the compound is:
or a pharmaceutically acceptable salt thereof.

### Claim 23 (depends on 1)

A pharmaceutical composition comprising a compound of claim 1, or a stereoisomer, pharmaceutically acceptable salt or prodrug thereof, and a pharmaceutically acceptable carrier, diluent or excipient.

### Claim 24 (depends on 1)

A method of treating a bacterial infection in a mammal comprising administering to a mammal in need thereof an effective amount of a compound of claim 1.

### Claim 25 (depends on 23)

A method of treating a bacterial infection in a mammal comprising administering to a mammal in need thereof an effective amount of a pharmaceutical composition of claim 23.

### Claim 26

A compound having the following structure (I):
or a stereoisomer, prodrug or pharmaceutically acceptable salt thereof,
wherein:
Q1 is hydroxyl, a protected hydroxyl, amino or a protected amino group;
Q2 is alkyl optionally substituted with one or more halogen, hydroxyl, amino, optionally substituted cycloalkyl or optionally substituted heterocyclyl,
Q5 is hydroxyl, a protected hydroxyl, amino or a protected amino group;
each R1 and R2 is, independently, hydrogen or an amino protecting group;
each R3 is, independently, hydrogen or a hydroxyl protecting group;
each R4, R5, R7 and R3 is, independently, hydrogen or C1-C6 alkyl optionally substituted with one or more halogen, hydroxyl or amino;
each R6 is, independently, hydrogen, halogen, hydroxyl, amino or C1-C6 alkyl;
or R4 and R5 together with the atoms to which they are attached can form a heterocyclic ring having from 4 to 6 ring atoms, or R5 and one R6 together with the atoms to which they are attached can form a heterocyclic ring having from 3 to 6 ring atoms, or R4 and one R6 together with the atoms to which they are attached can form a carbocyclic ring having from 3 to 6 ring atoms, or R7 and R8 together with the atom to which they are attached can form a heterocyclic ring having from 3 to 6 ring atoms;
each R9 is, independently, hydrogen, hydroxyl, amino or C1-C6 alkyl optionally substituted with one or more halogen, hydroxyl or amino;
each R10 is, independently, hydrogen, halogen, hydroxyl, amino or C1-C6 alkyl;
each R11 is, independently, hydrogen, halogen, amino or C1-C6 alkyl;
or R9 and one R11 together with the atoms to which they are attached can form a heterocyclic ring having from 3 to 6 ring atoms, or R4 and one R11 together with the atoms to which they are attached can form a carbocyclic ring having from 3 to 6 ring atoms;
each n is, independently, an integer from 0 to 4;
each p is, independently, an integer from 1 to 4; and
each Z1 and Z2 is, independently, hydrogen or —OR3,
wherein (i) at least one of Z1 and Z2 is H, and (ii) the two adjacent —CH— groups to which Z1 and Z2 are attached may optionally form a double bond.

### Claim 27 (depends on 26)

A compound of claim 26 wherein each R1, R2 and R3 are hydrogen.

### Claim 28

(canceled)

### Claim 29 (depends on 26)

A compound of claim 26 wherein Q5 is hydroxyl.

### Claim 30 (depends on 26)

A compound of claim 26 wherein Q1 is amino.

### Claim at position 27

31-32. (canceled)

### Claim 33 (depends on 26)

A compound of claim 26 wherein Z1 is hydroxyl and Z2 is hydrogen.

### Claim 34 (depends on 26)

A compound of claim 26 wherein Z1 is hydrogen and Z2 is hydroxyl.

### Claim at position 30

35-71. (canceled)

### Claim 72 (depends on 26)

A compound of claim 26 having the configuration:

### Claim 73

(canceled)

### Claim 74 (depends on 26)

A compound of claim 26 wherein the two adjacent carbon atoms to which Z1 and Z2 are attached form a single bond.

### Claim 75 (depends on 26)

A pharmaceutical composition comprising a compound of claim 26, or a stereoisomer, pharmaceutically acceptable salt or prodrug thereof, and a pharmaceutically acceptable carrier, diluent or excipient.

### Claim 76 (depends on 26)

A method of treating a bacterial infection in a mammal comprising administering to a mammal in need thereof an effective amount of a compound of claim 26.

### Claim 77 (depends on 75)

A method of treating a bacterial infection in a mammal comprising administering to a mammal in need thereof an effective amount of a pharmaceutical composition of claim 75.

### Claim 78

A compound having the following structure (INT-I):
wherein:
each R1 is, independently, an amino protecting group;
each R3 is, independently, a hydroxyl protecting group; and
each A is, independently, phenyl, optionally substituted with one or more halogen, hydroxyl, amino or C1-C6 alkyl optionally substituted with one or more halogen, hydroxyl or amino.

### Claim 79 (depends on 78)

A compound of claim 78 wherein the compound is:
